Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

NexMed Announces Decision For Anti-Fungal Product
NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® technology, announced the mutual decision with Novartis to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus. NexMed entered into the exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM100060.

BPA, Chemical Used To Make Plastics, Found To Leach From Polycarbonate Drinking Bottles Into Humans Exposure To BPA May Have Harmful Health Effects
A new study from Harvard School of Public Health (HSPH) researchers found that participants who drank for a week from polycarbonate bottles, the popular, hard-plastic drinking bottles and baby bottles, showed a two-thirds increase in their urine of the chemical bisphenol A (BPA). Exposure to BPA, used in the manufacture of polycarbonate and other plastics, has been shown to interfere with reproductive development in animals and has been linked with cardiovascular disease and diabetes in humans. The study is the first to show that drinking from polycarbonate bottles increased the level of urinary BPA, and thus suggests that drinking containers made with BPA release the chemical into the liquid that people drink in sufficient amounts to increase the level of BPA excreted in human urine.
News of the day
Provectus Completes Patient Accrual In Phase 2 Trial Of PV-10 For Metastatic Melanoma
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company has completed patient accrual and initial PV-10 treatment in its Phase 2 trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
Oncology

More Female Doctors Will Lead To Rising Demand For Locums, Says HCL

HCL, the UK"s largest specialist health and social care recruiter, said that the rising proportion of women doctors will lead to a greater emphasis on flexible working and the use of locums in the medical workforce. The company, which provides doctors of all grades and specialties to the NHS and private sector, was responding to a study by the Royal College of Physicians ("RCP") which forecasts that the majority of UK doctors in both hospitals and general practice will be female after 2017. The study shows that women currently account for 40% of all doctors, including 42% of GPs and 28% of consultants, and this proportion is set to increase significantly over the next eight years. Since women doctors overwhelmingly tend to prefer part time and flexible hours, this trend has considerable implications for medical workforce planning, with hospitals and GP surgeries having to rely increasingly on banks of temporary and flexible doctors, HCL said. Julian Cater, analyst at Collins Stewart, agreed. Raising HCL"s target price to 250p, he said: "The implication is clear that the gender shift within the NHS is going to steadily drive demand for more temporary employees over the medium-term." Kate Bleasdale, Executive Vice Chairman of HCL, said: "This re-balancing of the medical profession towards women is something that we have been predicting for some time. "The preference of women doctors for part time and flexible hours is well known, and will leave gaps in hospital rotas that will need to be filled by staffing companies like HCL, as well as more doctors seeking to work as locums. "We anticipate rising demand from our clients over the next few years as the proportion of doctors continues to shift toward women, and hospital managers have to be able to tap into a large bank of flexible and appropriately qualified doctors in order to ensure that rotas are sufficiently covered. And as locum work itself is an ideal way of working flexibly, we also anticipate a rise in the number of candidates signing up with us as the number of female doctors increases. "We are currently seeing momentous changes in the way the medical profession works in the UK: new restrictions on immigrant doctors, the European Working Time Directive, and now evidence of the rapidly increasing proportion of female doctors. "At HCL we are experienced in anticipating and planning for demographic changes such as these, and we are committed to working closely with the NHS and private sector to get the best results for both doctors and patients." HCL Plc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009